A detailed history of Commonwealth Equity Services, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 14,946 shares of ACAD stock, worth $256,622. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,946
Previous 14,770 1.19%
Holding current value
$256,622
Previous $240,000 4.17%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$15.14 - $19.14 $2,664 - $3,368
176 Added 1.19%
14,946 $230,000
Q2 2024

Jul 31, 2024

BUY
$14.62 - $18.42 $11,374 - $14,330
778 Added 5.56%
14,770 $240,000
Q1 2024

Apr 29, 2024

SELL
$17.79 - $30.86 $4,145 - $7,190
-233 Reduced 1.64%
13,992 $259,000
Q4 2023

Feb 06, 2024

BUY
$20.78 - $31.77 $12,883 - $19,697
620 Added 4.56%
14,225 $445,000
Q3 2023

Oct 23, 2023

SELL
$20.84 - $33.47 $17,714 - $28,449
-850 Reduced 5.88%
13,605 $284,000
Q2 2023

Aug 10, 2023

BUY
$17.8 - $25.65 $4,414 - $6,361
248 Added 1.75%
14,455 $346,000
Q1 2023

May 11, 2023

BUY
$16.32 - $20.92 $4,520 - $5,794
277 Added 1.99%
14,207 $267,000
Q4 2022

Feb 07, 2023

BUY
$14.2 - $18.63 $12,283 - $16,114
865 Added 6.62%
13,930 $221,000
Q3 2022

Nov 14, 2022

SELL
$14.11 - $18.27 $6,462 - $8,367
-458 Reduced 3.39%
13,065 $213,000
Q2 2022

Jul 19, 2022

BUY
$13.01 - $27.22 $1,261 - $2,640
97 Added 0.72%
13,523 $190,000
Q1 2022

May 04, 2022

SELL
$20.94 - $27.5 $13,129 - $17,242
-627 Reduced 4.46%
13,426 $325,000
Q4 2021

Jan 31, 2022

SELL
$16.79 - $27.09 $5,356 - $8,641
-319 Reduced 2.22%
14,053 $328,000
Q3 2021

Oct 29, 2021

SELL
$15.78 - $24.77 $18,004 - $28,262
-1,141 Reduced 7.36%
14,372 $238,000
Q2 2021

Aug 11, 2021

SELL
$19.4 - $27.42 $2,910 - $4,113
-150 Reduced 0.96%
15,513 $378,000
Q1 2021

May 04, 2021

SELL
$25.02 - $54.99 $3,377 - $7,423
-135 Reduced 0.85%
15,663 $404,000
Q4 2020

Feb 11, 2021

BUY
$41.04 - $56.79 $16,128 - $22,318
393 Added 2.55%
15,798 $844,000
Q3 2020

Nov 05, 2020

BUY
$36.42 - $57.0 $45,124 - $70,623
1,239 Added 8.75%
15,405 $635,000
Q2 2020

Aug 12, 2020

SELL
$39.26 - $52.73 $22,574 - $30,319
-575 Reduced 3.9%
14,166 $686,000
Q1 2020

May 11, 2020

BUY
$31.65 - $46.87 $5,064 - $7,499
160 Added 1.1%
14,741 $622,000
Q4 2019

Feb 05, 2020

BUY
$36.21 - $51.4 $59,746 - $84,810
1,650 Added 12.76%
14,581 $623,000
Q3 2019

Oct 30, 2019

SELL
$22.22 - $44.01 $18,798 - $37,232
-846 Reduced 6.14%
12,931 $465,000
Q2 2019

Jul 19, 2019

SELL
$23.32 - $28.12 $1,609 - $1,940
-69 Reduced 0.5%
13,777 $368,000
Q1 2019

May 13, 2019

SELL
$16.17 - $27.38 $1,778 - $3,011
-110 Reduced 0.79%
13,846 $371,000
Q4 2018

Feb 11, 2019

SELL
$14.32 - $22.92 $200 - $320
-14 Reduced 0.1%
13,956 $225,000
Q3 2018

Nov 06, 2018

BUY
$13.03 - $21.81 $6,554 - $10,970
503 Added 3.74%
13,970 $290,000
Q2 2018

Jul 31, 2018

SELL
$15.07 - $22.34 $7,881 - $11,683
-523 Reduced 3.74%
13,467 $206,000
Q1 2018

May 14, 2018

BUY
$22.47 - $32.33 $314,355 - $452,296
13,990 New
13,990 $314,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.78B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.